KAIVA STRATEGIES, LLC: public contracts won without a rival in United States: 37 uncontested awards; 49% of its awards; 36 without a competition; 1 single bid.
Assay record ASY-US-0YFXENP19E · Cite as: Assay Systems, “KAIVA STRATEGIES, LLC: public contracts won without a rival in United States”, https://assay-systems.com/register/us/uncontested/s/kaiva-strategies-llc/
KAIVA STRATEGIES, LLC won 37 of its 76 public contract awards in United States without a rival from 2023-10-16 to 2026-09-28, worth $56.1M: 36 without a competition and 1 after a competition that drew a single bid. 2 buyers awarded it without a rival, the largest Food and Drug Administration with 35.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
Food and Drug Administration gave KAIVA STRATEGIES, LLC 74 awards: 34 without a competition, 1 after a competition with a single bid. First 2023-10-16, latest 2026-09-28.
Centers for Disease Control and Prevention gave KAIVA STRATEGIES, LLC 2 awards: 2 without a competition, 0 after a competition with a single bid. First 2024-03-28, latest 2024-06-06.
| Date | Buyer | How | Value | Stated reason |
|---|---|---|---|---|
| 2026-09-11 | Food and Drug Administration 75F40126F19009 | No competition NOT AVAILABLE FOR COMPETITION | $2.9M | AUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I)) |
| 2025-09-17 | Food and Drug Administration 75F40125P00268 | Single bid COMPETED UNDER SAP | $1.1M | — |
| 2024-09-16 | Food and Drug Administration 75F40124C00127 | No competition NOT AVAILABLE FOR COMPETITION | $97.5K | AUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I)) |
| 2024-09-10 | Food and Drug Administration 75F40124C00092 | No competition NOT COMPETED | $4.2M | ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER) |
| 2024-08-28 | Food and Drug Administration 75F40124C00091 | No competition NOT COMPETED | $419K | ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER) |
| 2024-08-27 | Food and Drug Administration 75F40124C00097 | No competition NOT AVAILABLE FOR COMPETITION | $1.9M | AUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I)) |
Every uncontested award in United States · All countries · KAIVA STRATEGIES, LLC in the register
Source: USAspending.gov prime award transactions (contracts). Awards are matched to their buyer and supplier as published. Updated 17 October 2026.